Dectin-1 epigenetic reprogramming rescues senescent-like Treg function in allergic asthma
Life Science Alliance · 2026-06 · 9 (6) · e202503552
DOI: 10.26508/lsa.202503552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 17.03.2026. Verfasst von Xiangdong Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Rehabilitation Medicine, Henan Academy of Innovations in Medical Science, Zhengzhou, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Lectins, C-Type, Asthma, Epigenesis, Genetic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science, Technology Innovation Bureau of Shenzhen Municipality.
Abstract (Originalsprache)
Allergic asthma is characterized by immune dysregulation, and deficiencies in regulatory T-cell (Treg) function are a hallmark of the disease. However, mechanisms of Treg impairment for their therapeutic correction remain poorly defined. The results showed that patient Tregs exhibited a senescent phenotype, including shortened telomeres, increased SA-β-gal activity, and heightened apoptosis. Functionally, they were compromised, showing reduced suppressive capacity and a pro-inflammatory cytokine shift. KQS-1 treatment robustly reversed these defects, restoring FOXP3- and IL-10–dependent Treg suppressive capacity and the production of anti-inflammatory cytokines. This functional rescue centered on these two core Treg signature genes was dependent on Dectin-1 binding and a downstream Raf-1/ROS signaling axis, which drove a sustained epigenetic program characterized by increased H3K4me3 and H3K27ac at the FOXP3 and IL10 loci, focal hypomethylation, and chromatin remodeling at these specific loci. CRISPR-mediated deletion of Dectin-1 abrogated all beneficial effects of KQS-1. As proof of principle that KQS1 is protective, we demonstrate attenuation of airway hyperresponsiveness, inflammation, and remodeling in dust mite–sensitized mice and in recipient mice upon adoptive transfer of KQS-1–trained human Tregs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Rehabilitation Medicine, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
- Department of Gastroenterology, The Fifth Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
- State Key Laboratory of Respiratory Diseases, Allergy Division, Shenzhen University, Institute of Allergy and Immunology, Shenzhen University School of Medicine, Shenzhen Key Laboratory of Allergy and Immunology, Shenzh…
- Institute of Rehabilitation Medicine, Henan Academy of Innovations in Medical Science, Zhengzhou, China pcy2356@163.com.
- Institute of Rehabilitation Medicine, Henan Academy of Innovations in Medical Science, Zhengzhou, China doctorleee@hnsyxkxy.cn.
ORCID-Profile: Pingchang Yang, Liguo Li
Förderung
- National Natural Science Foundation of China
- Science, Technology Innovation Bureau of Shenzhen Municipality
Zitieren
APA
Sun, X., Duan, J., Liu, L., Ye, Y., Mi, Y., Zheng, P., Yang, P., & Li, L. (2026). Dectin-1 epigenetic reprogramming rescues senescent-like Treg function in allergic asthma. Life Science Alliance, 9(6), e202503552. https://doi.org/10.26508/lsa.202503552
Vancouver
Sun X, Duan J, Liu L, Ye Y, Mi Y, Zheng P, et al. Dectin-1 epigenetic reprogramming rescues senescent-like Treg function in allergic asthma. Life Science Alliance. 2026;9(6):e202503552. doi:10.26508/lsa.202503552
BibTeX
@article{Sun2026,
author = {Sun, Xiangdong and Duan, Jiaqi and Liu, Le and Ye, Yanyu and Mi, Yang and Zheng, Pengyuan and Yang, Pingchang and Li, Liguo},
title = {Dectin-1 epigenetic reprogramming rescues senescent-like Treg function in allergic asthma},
journal = {Life Science Alliance},
year = {2026},
volume = {9},
number = {6},
pages = {e202503552},
doi = {10.26508/lsa.202503552}
}
EUVIMED